Share This:
https://ntp.niehs.nih.gov/go/15768

TDMS Study 96020-01 Pathology Tables

NTP Experiment-Test: 96020-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT18
Study Type: CHRONIC                                  WITH AVERAGE SEVERITY GRADES[b]                              Date: 03/03/04
Route: GAVAGE                                  TEF EVALUATION (BINARY MIXTURE; PCB 126/PCB 153)                   Time: 13:41:38

                                                     31 WEEK SSAC FINAL #1




       Facility:  Battelle Columbus Laboratory

       Chemical CAS #:  TEFBINARYMIX

       Lock Date:  03/27/02

       Cage Range:  All

       Reasons For Removal:    25017 Scheduled Sacrifice

       Removal Date Range:     04/14/99 - 04/15/99

       Treatment Groups:       Include 001    0 NG /  0 UG
                               Include 002    10 NG / 10 UG
                               Include 003    100 NG /100 UG
                               Include 005    300 NG /300 UG
                               Include 007    1000 NG/1000 UG





























a  Number of animals examined microscopically at site and number of animals with lesion
b  Average severity grade (1-minimal;2-mild;3-moderate;4-marked)

                                                              Page   1


NTP Experiment-Test: 96020-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT18  
Study Type: CHRONIC                                  WITH AVERAGE SEVERITY GRADES[b]                              Date: 03/03/04    
Route: GAVAGE                                  TEF EVALUATION (BINARY MIXTURE; PCB 126/PCB 153)                   Time: 13:41:38    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         SPRAGUE-DAWLEY RATS FEMALE                   0 NG /       10 NG /      100 NG /     300 NG /     1000 NG/                  
                                                      0 UG         10 UG        100 UG       300 UG       1000 UG                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          98           86           98           98           98                        
                                                                                                                                    
  Scheduled Sacrifice                                 16           10           16           16           16                        
  Early Deaths                                                                                                                      
  Survivors                                                                                                                         
                                                                                                                                    
  Animals Examined Microscopically                    10           10           10           10           10                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Liver                                              (10)         (10)         (10)         (10)         (10)                      
      Clear Cell Focus                                              1                                                               
      Fatty Change, Diffuse                                                                   1 [1.0]     10 [2.1]                  
      Inflammation                                    10 [1.0]     10 [1.0]     10 [1.1]     10 [1.0]     10 [1.6]                  
      Mixed Cell Focus                                 1                         2            3            2                        
      Mixed Cell Focus, Multiple                       1            1            1            3            3                        
      Pigmentation                                                               3 [1.0]     10 [1.0]     10 [1.2]                  
      Toxic Hepatopathy                                                                                    5 [1.0]                  
      Bile Duct, Hyperplasia                                                                  1 [1.0]      2 [1.0]                  
      Bile Duct, Inflammation, Chronic Active,                                                                                      
         Focal                                                                                             1 [2.0]                  
      Hepatocyte, Hypertrophy                                       3 [1.0]      5 [1.0]     10 [1.0]     10 [3.2]                  
      Hepatocyte, Multinucleated                                                                           9 [1.2]                  
   Pancreas                                           (10)         (10)         (10)         (10)         (10)                      
      Basophilic Focus                                                                        1                                     
      Inflammation, Chronic Active                     1 [1.0]      1 [1.0]                   1 [1.0]                               
      Acinus, Atrophy                                  1 [1.0]      1 [1.0]                   1 [1.0]                               
      Acinus, Vacuolization Cytoplasmic                                                                    3 [1.0]                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (10)         (10)         (10)         (10)         (10)                      
      Degeneration, Cystic                                          1 [1.0]      1 [2.0]                                            
      Hyperplasia                                                                             1 [1.0]      2 [2.5]                  
      Hypertrophy                                      3 [1.0]      2 [1.0]      2 [1.5]      4 [1.0]      1 [1.0]                  
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
b  Average severity grade (1-minimal;2-mild;3-moderate;4-marked)                                                                    
                                                                                                                                    
                                                             Page    2                                                              
                                                                                                                                   
NTP Experiment-Test: 96020-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT18  
Study Type: CHRONIC                                  WITH AVERAGE SEVERITY GRADES[b]                              Date: 03/03/04    
Route: GAVAGE                                  TEF EVALUATION (BINARY MIXTURE; PCB 126/PCB 153)                   Time: 13:41:38    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         SPRAGUE-DAWLEY RATS FEMALE                   0 NG /       10 NG /      100 NG /     300 NG /     1000 NG/                  
                                                      0 UG         10 UG        100 UG       300 UG       1000 UG                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Vacuolization Cytoplasmic                                                                            1 [1.0]                  
   Thyroid Gland                                      (10)         (10)         (10)         (10)         (10)                      
      Follicular Cell, Hypertrophy                                  5 [1.0]      5 [1.0]      7 [1.0]      8 [1.4]                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Ovary                                              (10)         (10)         (10)         (10)         (10)                      
      Atrophy                                          6 [4.0]      7 [4.0]      9 [4.0]     10 [4.0]      6 [4.0]                  
   Uterus                                             (10)         (10)         (10)         (10)         (10)                      
      Inflammation, Suppurative                        1 [2.0]      1 [2.0]                                                         
      Metaplasia, Squamous                             6 [1.7]      7 [2.0]      5 [1.8]      9 [2.2]      4 [1.8]                  
      Endometrium, Hyperplasia, Cystic                              1 [4.0]      1 [4.0]                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Lymph Node                                                                   (1)                                                 
      Mediastinal, Inflammation, Granulomatous                                   1 [3.0]                                            
   Spleen                                             (10)                                                                          
      Pigmentation                                    10 [1.0]                                                                      
   Thymus                                             (10)         (10)         (10)         (10)         (10)                      
      Atrophy                                          6 [1.2]      5 [1.2]      6 [1.0]      7 [1.0]     10 [1.9]                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   None                                                                                                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
b  Average severity grade (1-minimal;2-mild;3-moderate;4-marked)                                                                    
                                                                                                                                    
                                                             Page    3                                                              
                                                                                                                                   
NTP Experiment-Test: 96020-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT18  
Study Type: CHRONIC                                  WITH AVERAGE SEVERITY GRADES[b]                              Date: 03/03/04    
Route: GAVAGE                                  TEF EVALUATION (BINARY MIXTURE; PCB 126/PCB 153)                   Time: 13:41:38    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         SPRAGUE-DAWLEY RATS FEMALE                   0 NG /       10 NG /      100 NG /     300 NG /     1000 NG/                  
                                                      0 UG         10 UG        100 UG       300 UG       1000 UG                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (10)         (10)         (10)         (10)         (10)                      
      Hemorrhage                                                                              1 [1.0]                               
      Infiltration Cellular, Histiocyte                2 [1.0]      1 [1.0]                   1 [1.0]      4 [1.0]                  
      Inflammation                                                  1 [1.0]                                                         
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   None                                                                                                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
b  Average severity grade (1-minimal;2-mild;3-moderate;4-marked)                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page    4                                                              
                                                                                                                                   
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------